Saturday, April 19, 2025
Home Authors Posts by Editor / Curator

Editor / Curator

937 POSTS 0 COMMENTS
Biotech News

Adding Brainstorm Therapeutics (BCLI) $4.59 to CoronaVirus Watchlist.

Editor / Curator -
Stem Cells

Heads Up! Big News on Stem Cells & Covid This Weekend.

Editor / Curator -
OMNIQ
Cybersecurity

First Zebra (ZBRA) Then Checkpoint (CHKP), OMNIQ (OQMS) Strengthens Product Line-Up.

Editor / Curator -
Satori Capital. Hapbee
Telehealth

Investment Manager With $1 Billion in Assets Under Management, Buys 300...

Editor / Curator -
Internet Stock Review
Bitcoin

And We Have Our First Bitcoin Double.

Editor / Curator -
Biotech News

Adding ENDRA Life Sciences (NDRA) $0.89 to Watch List.

Editor / Curator -
Biotech Stock Review
Biotech News

Video: Okay, You Tested Positive for Corona, Now What?

Editor / Curator -
Hepion Pharma HEPA
Biotech News

News, As Huge As It Gets, From Hepion Pharma (HEPA) $2.10.

Editor / Curator -
Hapbee, EMulate, HAPB
Telehealth

A Medical Technology That Has The Highest Potential Over Any ...

Editor / Curator -
All News

OTC Markets Group Welcomes Direct Communication Solutions (DCSX), Inc. to OTCQX

Editor / Curator -
1...545556...94Page 55 of 94

Latest article

Epidemic Denial: RFK Jr. Holds Press Conference on new Autism findings from the CDC

All News Editor / Curator -
Health and Human Services Secretary Robert F. Kennedy Jr. will be joined by officials on Wednesday to discuss the latest Autism and...

GeoVax (GOVX) Down on JFK’s Continued Scale Backs to the Vaccine Sector.

2025 Watch List Editor / Curator -
Down 20% in response to news in an 8K that the Biomedical Advanced Research and Development Authority BARDA (also once known as the...

Adding Allarity (ALLR) $0.70, to Watch List.

2025 Watch List Editor / Curator -
LIVE QUOTE SHORT TERM CHART Bargain Hunting? Adding to the...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.